Cryofocus Medtech (Shanghai) Co., Ltd. (HKG:6922)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.900
-0.050 (-1.01%)
At close: May 29, 2026
Market Cap1.20B +6.2%
Revenue (ttm)106.02M +78.0%
Net Income-42.47M
EPS-0.18
Shares Out 244.71M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume65,600
Open4.990
Previous Close4.950
Day's Range4.760 - 4.990
52-Week Range4.030 - 8.000
Beta-0.85
Analystsn/a
Price Targetn/a
Earnings DateAug 7, 2026

About HKG:6922

Cryofocus Medtech (Shanghai) Co., Ltd., a medical device company, engages in the research and development, manufacture, and sale of cryoablation minimally invasive interventional treatment technology and related medical products in the People’s Republic of China. The company develops products in the areas of vascular interventional therapy for the treatment of atrial fibrillation, hypertension, and other cardiovascular diseases; and natural orifice transluminal endoscopic surgery for the treatment of urinary, respiratory, and digestive diseases... [Read more]

Sector Healthcare
Founded 2013
Employees 180
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6922
Full Company Profile

Financial Performance

In 2025, HKG:6922's revenue was 95.27 million, an increase of 77.97% compared to the previous year's 53.53 million. Losses were -38.17 million, -63.43% less than in 2024.

Financial numbers in CNY Financial Statements